Technologies Available for Partnering
Our commitment to innovative research spans a wide spectrum of technologies. From uncovering novel therapeutic targets and pioneering precise diagnostics platforms to harnessing the power of artificial intelligence to expedite the pace of discovery, we push the boundaries of what’s possible in the fight against cancer and related disease.
Showing 25-36 of 54
Targeting TIRR for Cancer Therapy: A Novel Target for Reactivating Lost p53 Suppressor Activity
- Collaboration
- Investment
- Licensing
Treating Hematological Malignancies Such as Multiple Myeloma Targeting Extracellular Cyclophilin A (eCyPA) and CD147
- Collaboration
- Licensing
KDM5 Selective Inhibitors for the Treatment of Multiple Myeloma and Other KDM-dependent Diseases
- Licensing
A New Mechanism for Inhibiting BCL9 in a Poor Prognosis Subtype of Colorectal Cancer
- Collaboration
- Licensing
BCMA-Specific Immunotherapy Approaches to Multiple Myeloma
- Collaboration
- Investment
- Licensing